- Home
- ZNTL vs PSTL Comparison
ZNTL vs PSTL Comparison
Compare ZNTL & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- PSTL
- Stock Information
- Founded
- ZNTL 2014
- PSTL 2018
- Country
- ZNTL United States
- PSTL United States
- Employees
- ZNTL N/A
- PSTL N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- PSTL Real Estate Investment Trusts
- Sector
- ZNTL Health Care
- PSTL Real Estate
- Exchange
- ZNTL Nasdaq
- PSTL Nasdaq
- Market Cap
- ZNTL 238.2M
- PSTL 320.0M
- IPO Year
- ZNTL 2020
- PSTL 2019
- Fundamental
- Price
- ZNTL $3.12
- PSTL $14.62
- Analyst Decision
- ZNTL Buy
- PSTL Buy
- Analyst Count
- ZNTL 7
- PSTL 2
- Target Price
- ZNTL $10.86
- PSTL $15.75
- AVG Volume (30 Days)
- ZNTL 1.2M
- PSTL 67.9K
- Earning Date
- ZNTL 11-04-2024
- PSTL 11-01-2024
- Dividend Yield
- ZNTL N/A
- PSTL 6.58%
- EPS Growth
- ZNTL N/A
- PSTL N/A
- EPS
- ZNTL N/A
- PSTL 0.09
- Revenue
- ZNTL $40,560,000.00
- PSTL $68,445,000.00
- Revenue This Year
- ZNTL N/A
- PSTL N/A
- Revenue Next Year
- ZNTL N/A
- PSTL $12.21
- P/E Ratio
- ZNTL N/A
- PSTL $167.49
- Revenue Growth
- ZNTL N/A
- PSTL 15.46
- 52 Week Low
- ZNTL $2.83
- PSTL $13.00
- 52 Week High
- ZNTL $18.24
- PSTL $15.15
- Technical
- Relative Strength Index (RSI)
- ZNTL 44.34
- PSTL 55.79
- Support Level
- ZNTL $2.92
- PSTL $14.46
- Resistance Level
- ZNTL $3.23
- PSTL $14.73
- Average True Range (ATR)
- ZNTL 0.17
- PSTL 0.19
- MACD
- ZNTL 0.00
- PSTL 0.04
- Stochastic Oscillator
- ZNTL 38.33
- PSTL 84.87
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.